dNTP Mix (2.5 mM)
dNTP Mix (2.5 mM)
Invitrogen™

dNTP Mix (2.5 mM)

Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP,深入閱讀
Have Questions?
產品號碼Quantity
R725011 mL
產品號碼 R72501
價格 (HKD)
1,132.00
線上優惠
Ends: 31-Dec-2025
1,581.00
您節省 449.00 (28%)
Each
新增至購物車
Quantity:
1 mL
Request bulk or custom format
價格 (HKD)
1,132.00
線上優惠
Ends: 31-Dec-2025
1,581.00
您節省 449.00 (28%)
Each
新增至購物車

Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP, each at a concentration of 2.5 mM. It is supplied in purified water and neutralized to pH 8.0 with NaOH. 2.5 mM dNTP Mix is suitable for use in a wide variety of molecular applications.

Applications
• Traditional PCR
• Sequencing
• cDNA synthesis
• Nick translation
• TdT-tailing reactions

For Research Use Only. Not for use in diagnostic procedures.
規格
Quantity1 mL
Shipping ConditionDry Ice
Concentration2.5 mM
For Use With (Application)Standard PCR
FormLiquid
Label or DyeUnlabeled
Unit SizeEach
內容物與存放
dNTP Mix, 2.5 mM (2 x 500 μL)

Store at –20°C.

引用資料與參考文獻 (1)

引用資料與參考文獻
Abstract
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Authors: Blanco J G; Dervieux T; Edick M J; Mehta P K; Rubnitz J E; Shurtleff S; Raimondi S C; Behm F G; Pui C H; Relling M V;
Journal:Proc Natl Acad Sci U S A
PubMed ID:11526240
Therapy-related acute myeloid leukemias (t-AML) with translocations of the MLL gene are associated with the use of topoisomerase II inhibitors. We established the emergence of the malignant clone in a child who developed t-AML with a t(11;19) (q23;p13.3) during treatment for acute lymphoblastic leukemia (ALL). The MLL-ENL and the reciprocal ... More